Population Prevalence of Personality Disorder and Associations With Physical Health Comorbidities and Health Care Service Utilization: A Review

Grants

Funding Acknowledgements

Shae E. Quirk was supported by a National Health and Medical Research Council (NHMRC) of Australia Postgraduate Scholarship (Grant 1076347). Michael Berk has received grant/research support from the National Institute of Health (USA), Simons Foundation, CRC for Mental Health, Stanley Medical Research Institute, Medical Benefits Fund, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma, Servier and Astra Zeneca. He has been a paid consultant for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, and Pfizer and a paid speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Organon, Pfizer, Sanofi Synthelabo, Solvay, and Wyeth, and is supported by a NHMRC Senior Principal Research Fellowship (Grant 1059660). Andrew M. Chanen has received research funding from the NHMRC, Australian Research Council, Colonial Foundation, the University of Melbourne, and the New South Wales Department of Health. Sharon L. Brennan-Olsen has received Grant/Research support from The University of Melbourne, Deakin University, Arthritis Australia, Arthritis Victoria, Australian Association of Gerontology, and Barwon Orthopaedic Research Trust, and is supported by an Alfred Deakin Postdoctoral Research Fellowship. Julie A. Pasco has received Grant/Research support from the NHMRC, BUPA Foundation, Deakin University, Barwon Health and the Western Alliance and has received speaker fees from Amgen and Sanofi Aventis. Lana J. Williams has received grant/research support from Eli Lilly, Pfizer, the University of Melbourne, Deakin University, the NHMRC, and is supported by a NHMRC Career Development Fellowship (Grant 1064272).